People with Impaired Glucose Tolerance and Impaired Fasting Glucose Are Similarly Susceptible to Cardiovascular Disease: A Study in First-Degree Relatives of Type 2 Diabetic Patients

被引:11
作者
Amini, Massoud [1 ]
Horri, Negar [1 ]
Zare, Maryam [1 ]
Haghighi, Sassan [1 ]
Hosseini, Seyed Mohsen [2 ]
Aminorroaya, Ashraf [1 ]
Hovsepian, Silva [1 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan 8187698191, Iran
[2] Isfahan Univ Med Sci, Dept Epidemiol & Biostat, Esfahan 8187698191, Iran
关键词
Cardiovascular disease; Risk factors; Impaired glucose tolerance; Impaired fasting glucose; First-degree relatives; Type; 2; diabetes; RISK-FACTORS; INDIVIDUALS; GLYCEMIA; MORTALITY;
D O I
10.1159/000294752
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: To compare the cardiovascular disease (CVD) risk factors between subjects with impaired fasting glucose (IFG) and those with impaired glucose tolerance (IGT) in the first-degree relatives (FDR) of type 2 diabetic patients. Methods: A cross-sectional study, conducted between 2004 and 2006 in 1,893 (1,412 females and 481 males) FDR of type 2 diabetic outpatients of the Isfahan Endocrine and Metabolism Research Center. In all participants, blood pressure, weight, height, waist circumference, serum lipids and HbA1c were measured and a standard 75-g 2-hour oral glucose tolerance test was performed. The diagnosis of IGT, IFG and diabetes was made according to American Diabetes Association criteria. Results: Isolated IGT and isolated IFG, and both IFG and IGT were observed in 8.8%, 17.4% and 11.2% of subjects, respectively. In comparison to subjects with normal glucose levels and tolerance (control group): the mean waist circumference was significantly higher in both IFG and IGT groups; BMI, HDL-c and LDL-c in the IFG group; and triglycerides in the IGT group. The means of all studied CVD risk factors were significantly higher in the IGT+IFG group than the control group, except for blood pressure, HDL-c and HbA1c. No significant differences were found regarding CVD risk factors between IFG and IGT groups. Conclusions: The prevalence of IFG and IGT is high in FDR of type 2 diabetic patients. CVD risk factors are similar in these 2 groups and higher than in the control group. More attention should be paid to screening and treatment of this high-risk population. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:267 / 272
页数:6
相关论文
共 29 条
  • [1] Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
  • [2] Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors - Results from the Baltimore Longitudinal Study on Aging
    Blake, DR
    Meigs, JB
    Muller, DC
    Najjar, SS
    Andres, R
    Nathan, DM
    [J]. DIABETES, 2004, 53 (08) : 2095 - 2100
  • [3] Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria
    Borch-Johnsen, K
    Neil, A
    Balkau, B
    Larsen, S
    Nissinen, A
    Pekkanen, J
    Tuomilehto, J
    Jousilahti, P
    Lindstrom, J
    Pyörälä, M
    Pyörälä, K
    Eschwege, E
    Gallus, G
    Garancini, MP
    Bouter, LM
    Dekker, JM
    Heine, RJ
    Nijpels, HG
    Stehouwer, CDA
    Feskens, EJM
    Kromhout, D
    Peltonen, M
    Pajak, A
    Eriksson, J
    Qiao, Q
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) : 397 - 405
  • [4] Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, DIABETES CARE, V26, DOI DOI 10.2337/DIACARE.26.2007.S5
  • [5] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [6] FULLER JH, 1980, LANCET, V1, P1373
  • [7] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [8] Gavin JR, 2000, DIABETES CARE, V23, pS4
  • [9] Younger age of escalation of cardiovascular risk factors in Asian Indian subjects
    Gupta, Rajeev
    Misra, Anoop
    Vikram, Naval K.
    Kondal, Dimple
    Sen Gupta, Shaon
    Agrawal, Aachu
    Pandey, R. M.
    [J]. BMC CARDIOVASCULAR DISORDERS, 2009, 9
  • [10] Hadaegh F, 2009, J ENDOCRINOL INVEST, V32, P724, DOI [10.1007/BF03346527, 10.3275/6399]